The global Microfluidics Market was valued at USD 41.9 billion in 2025 and is projected to grow from USD 46.9 billion in 2026 to USD 105.1 billion by 2033, registering a CAGR of 12.2% from 2026 to 2033. North America accounted for the largest revenue share of 42.8% in 2025, driven by the rapid adoption of microfluidic technologies across diagnostics, biomedical research, drug...

The Aptamers Market is opening new avenues in biotechnology and pharmaceuticals due to its unique binding properties and versatility. Aptamers are increasingly used in disease diagnostics, targeted therapies, and biomarker detection. Their synthetic nature allows easy modification, enhancing efficacy and stability. The market benefits from technological convergence, including integration with...